Bivalirudin use in patients undergoing percutaneous coronary intervention for acute myocardial infarction. Insights from the prospective, multi-centre EUROVISION registry.

Conclusions: Bivalirudin usage in the setting of primary PCI provided excellent results in terms of 30-day outcome even in a real-world population.
PMID: 25101656 [PubMed - as supplied by publisher]

Source: Acute Cardiac Care - August 7, 2014 Category: Cardiology Authors: Limbruno U, Picchi A, Galli S, Huber K, Lipiecki J, Bernstein D, Deliargyris E, Anthopoulos P, Nienaber C, Hamon M Tags: Acute Card Care Source Type: research